Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs ...

With a strong start to fiscal 2026, NetraMark is reiterating its previously stated guidance of achieving C$8–$10 million in booked contract backlog by mid-2026. This outlook is ...

Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

Digital Marketing Strategists: Storytellers who combine algorithms and audiences, they use AI to interpret analytics and ...

This article explores how challenges such as sequence optimization, immune activation and off-target effects are being ...

NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming ...

The digital health revolution is accelerating at an unprecedented pace, transforming how we diagnose diseases, deliver care, and manage wellness. From AI-powere ...

Attendees interested in learning more about CoSara products, including the TB and HPV tests on the Company's upcoming Co-Dx PCR platform, are encouraged to stop by at VIROCON 2025. CoSara will be ...

The rise of healthcare content creators and the challenge of misinformation If you work in healthcare and want to see if you ...

The world of scientific research is evolving at a remarkable pace. Across every field, from biotechnology and chemistry to ...

Nandkumar M. Kamat As the year is about to end, here is a short review of important breakthroughs in science that defined the ...

Preclinical data findings illustrate power of Cellarity’s discovery platform, which leverages transcriptomics and AI to discover previously unseen biological pathways to create novel cell ...